Article Versions Notes

Żuk M, Gawęda W, Majkowska-Pilip A, Osial M, Wolski M, Bilewicz A, Krysiński P. Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy. Pharmaceutics. 2021; 13(11):1843. https://doi.org/10.3390/pharmaceutics13111843

Żuk, Michał, Weronika Gawęda, Agnieszka Majkowska-Pilip, Magdalena Osial, Marcin Wolski, Aleksander Bilewicz, and Paweł Krysiński. 2021. "Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy" Pharmaceutics 13, no. 11: 1843. https://doi.org/10.3390/pharmaceutics13111843

Żuk, M., Gawęda, W., Majkowska-Pilip, A., Osial, M., Wolski, M., Bilewicz, A., & Krysiński, P. (2021). Hybrid Radiobioconjugated Superparamagnetic Iron Oxide-Based Nanoparticles for Multimodal Cancer Therapy. Pharmaceutics, 13(11), 1843. https://doi.org/10.3390/pharmaceutics13111843